TA
Troy A. Ignelzi bought $144K of RAPP stock
Troy A. Ignelzi, Chief Financial Officer of Rapport Therapeutics, Inc. (RAPP), bought 5,500 shares of RAPP stock worth $144K, per an SEC Form 4 filed Oct 21, 2026.
It was an open-market purchase.
The trade was reported on Oct 21, 2026.
RAPP has moved +4.3% since the trade date, from $25.06 to $26.15 (Nov 13, 2026 close).
- Traded
- Oct 21, 2026
- Disclosed
- Oct 21, 2026
- Filing delay
- 0 days
- Price since
- +4.3%
- Role
- Chief Financial Officer
- Source
- SEC Form 4